Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics and machine learning-based profiling of severity signatures in Mycoplasma pneumoniae infection in children. | iScience | 2026 | 41732270 | PubTator, text mining | PubMed |
| Covalent capture and genetic code expansion enables chemoproteomic profiling and functional characterization of lysine acetoacetylation. | Sci Adv | 2026 | 41719395 | PubTator, text mining | PubMed |
| A Unique Case of Concomitant T-Prolymphocytic Leukemia and B-Cell Acute Lymphoblastic Leukemia. | EJHaem | 2026 | 41716292 | PubTator, text mining | PubMed |
| Molecular background of Philadelphia chromosome dependent enhancement of cellular growth and tyrosine kinase inhibitor sensitivity. | Exp Hematol Oncol | 2026 | 41715231 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of Novel Oxime-Ether Derivatives of Spinosyn A as ASS1 Activators and Antitumor Agents. | J Med Chem | 2026 | 41673957 | PubTator, text mining | PubMed |
| Diel transcriptional dynamics of a marine sponge and its microbiome in a natural environment. | Anim Microbiome | 2026 | 41645277 | PubTator, text mining | PubMed |
| Lys-ing the Resistance: Targeting Lysosomes to Overcome Chemoresistance in Ovarian Cancer. | Curr Oncol Rep | 2026 | 41642562 | PubTator, text mining | PubMed |
| Spatial proteomics reveals layer-specific molecular landscapes and keratin 17-mediated inflammatory crosstalk in oral lichen planus of the tongue. | Br J Dermatol | 2026 | 41640051 | PubTator, text mining | PubMed |
| Metabolomic profiling and stable isotope tracing of human schwannomas: A novel perspective on tumor biology and radiation response. | Neurooncol Adv | 2026 | 41635804 | PubTator, text mining | PubMed |
| The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma. | J Transl Med | 2026 | 41629949 | PubTator, text mining | PubMed |
| Hallmarks of nuclear metabolism: implications for genome integrity, nuclear signaling, and therapeutic targeting. | NPJ Metab Health Dis | 2026 | 41629581 | PubTator, text mining | PubMed |
| Integrating next-generation sequencing with biochemical screening to optimize first-tier newborn screening systems. | Hum Genomics | 2026 | 41547924 | PubTator, text mining | PubMed |
| Progressive fibrosis in human MASLD is associated with spatially linked transcriptomic signatures of metabolic reprogramming and senescence. | JHEP Rep | 2026 | 41541503 | PubTator, text mining | PubMed |
| Spinosyn A derivatives as ASS1 activators and tumor inhibitors. | Bioorg Med Chem Lett | 2026 | 41519209 | PubTator, text mining | PubMed |
| Amino acid metabolic reprogramming in clear cell renal cell carcinoma: Pathogenic mechanisms and therapeutic targeting. | Cancer Lett | 2026 | 41494569 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic analysis reveals canonical and novel pathways modulated by nanoceria in mammalian retinal degeneration. | Sci Rep | 2026 | 41484209 | PubTator, text mining | PubMed |
| Long-term performance of a woodchip-based field-scale biofilter for arsenic removal from neutral mine drainage under cold climate. | Water Res | 2026 | 41106269 | PubTator, text mining | PubMed |
| 99 Chinese ASS1 carriers: Genetics, metabolism, and citrulline levels. | Clin Chim Acta | 2026 | 40683404 | PubTator, text mining | PubMed |
| Current Therapies and Potential Strategies for Uveal Melanoma. | Drugs Drug Candidates | 2025 | 41737289 | PubTator, text mining | PubMed |
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=4